706 related articles for article (PubMed ID: 32249490)
1. Systematic characterization of non-coding RNAs in triple-negative breast cancer.
Mei J; Hao L; Wang H; Xu R; Liu Y; Zhu Y; Liu C
Cell Prolif; 2020 May; 53(5):e12801. PubMed ID: 32249490
[TBL] [Abstract][Full Text] [Related]
2. Progress of non-coding RNAs in triple-negative breast cancer.
Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
[TBL] [Abstract][Full Text] [Related]
3. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
Wang Q; Gao S; Li H; Lv M; Lu C
J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
Xia M; Zu X; Chen Z; Wen G; Zhong J
Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs, another side of immune regulation during triple-negative breast cancer.
Alghazali MW; Al-Hetty HRAK; Ali ZMM; Saleh MM; Suleiman AA; Jalil AT
Pathol Res Pract; 2022 Nov; 239():154132. PubMed ID: 36183439
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
8. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.
Kong X; Liu W; Kong Y
J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
Feng Q; Zhang H; Yao D; Chen WD; Wang YD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
[TBL] [Abstract][Full Text] [Related]
13. Identification of long non‑coding RNA‑mediated transcriptional dysregulation triplets reveals global patterns and prognostic biomarkers for ER+/PR+, HER2‑ and triple negative breast cancer.
Du Z; Gao W; Sun J; Li Y; Sun Y; Chen T; Ge S; Guo W
Int J Mol Med; 2019 Sep; 44(3):1015-1025. PubMed ID: 31257479
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
15. Systematic characterization and biological functions of non-coding RNAs in glioblastoma.
Dai L; Liang W; Shi Z; Li X; Zhou S; Hu W; Yang Z; Wang X
Cell Prolif; 2023 Mar; 56(3):e13375. PubMed ID: 36457281
[TBL] [Abstract][Full Text] [Related]
16. The role of long non-coding RNAs and circular RNAs in bone regeneration: Modulating miRNAs function.
Ping J; Li L; Dong Y; Wu X; Huang X; Sun B; Zeng B; Xu F; Liang W
J Tissue Eng Regen Med; 2022 Mar; 16(3):227-243. PubMed ID: 34958714
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs-mediated cell fate in triple negative breast cancers.
Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
[TBL] [Abstract][Full Text] [Related]
18. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
19. The long non-coding RNA landscape in triple-negative breast cancer.
Zhang W; Guan X; Tang J
Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs: New Players in Cancers.
Chen X; Fan S; Song E
Adv Exp Med Biol; 2016; 927():1-47. PubMed ID: 27376730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]